| Metric | შპს ფორტრეს ფარმასიუტიკალ თრეიდინგ | სს საქართველოს ბანკი |
|---|---|---|
| Growth | ||
| Revenue | ₾10.6m₾19.5m | ₾2.70bn₾2.32bn |
| Revenue growth | -45.9% | 16.6% |
| Profitability | ||
| EBITDA | ₾817k₾790k | — |
| EBITDA margin | 7.7%4.1% | — |
| Net profit | ₾382k₾790k | ₾1.84bn₾1.33bn |
| Net margin | 3.6%4.1% | 68.1%57.6% |
| Balance sheet | ||
| Total assets | ₾9.1m₾17.3m | ₾39.27bn₾31.39bn |
| Total equity | -₾5.8m₾3.8m | ₾5.63bn₾4.45bn |
| ROE | —21.1% | 32.6%30.0% |